MTOR and colorectal cancer: Similarly, a ruthenium complex with 5-fluorouracil inhibited Akt/mTOR signaling [33], and a ruthenium-xanthoxyline complex targeted the Hsp90 chaperone [34] in HCT116 colorectal cancer cells.